Meeting
2024 ASCO Annual Meeting
Acceptability of stool-based DNA colorectal cancer (CRC) screening among Black/African American patients served by a Federally Qualified Health Center (FQHC).
Authors
Evan Keiser
Department of Medicine, University of Wisconsin, Madison, WI
Evan Keiser , A. Michelle Corbett , Onyema Chido-Amajuoyi , Allison Antoine , Carrie Stehman , Isabella Dorn , David Goines , Noelle K. LoConte
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 10530)
DOI
10.1200/JCO.2024.42.16_suppl.10530
Abstract #
10530
Poster Bd #
57
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
The challenge of colorectal cancer (CRC) screening in low and middle-income countries (LMIC): Acceptance, knowledge, and preferences in Brazil.
First Author: Victor Filogonio
Poster
2024 ASCO Annual Meeting
Non-invasive colorectal cancer detection using multimodal deep learning ensemble classifier.
First Author: Seung Wook Hong
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Trends in colorectal cancer screening from NHIS survey: Analysis of modalities impact on overall screening.
First Author: Derek W. Ebner
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of revising colorectal cancer screening guidelines on health care resources in Canada.
First Author: Brendan Chia